[ Price : $8.95]
FDA approves an Ocular Therapeutix supplemental NDA to broaden Dextenzas (dexamethasone ophthalmic insert) label to add an additio...[ Price : $8.95]
FDA approves Enzyvant Therapeutics thymus tissue-based product Rethymic for treating pediatric patients with congenital athymia, a...[ Price : $8.95]
Athenex decides to abandon its continued development of oral paclitaxel plus encequidar for treating metastatic breast cancer afte...[ Price : $8.95]
FDA grants Y-mAbs Therapeutics a rare pediatric disease designation for the companys lutetium-labeled omburtamab antibody program ...[ Price : $8.95]
FDA approves a ChemoCentryx NDA for Tavneos (avacopan) as an add-on treatment for adult patients with severe active anti-neutroph...[ Price : $8.95]
FDAs Antimicrobial Drugs Advisory Committee votes 17-0 to recommend approval of Takedas maribavir to treat cytomegalovirus infecti...[ Price : $8.95]
Federal Register notice: FDA announces a final guidance entitled Surgical Staplers and Staples for Internal Use Labeling Recommen...[ Price : $8.95]
Federal Register notice: FDA issues a final order to reclassify surgical staplers for internal use from Class 1 into Class 2 and s...